Table 1.
Studies examining direct evidence of GABAergic and glutamatergic abnormalities
| Study | Method | Target | N | ROIs | Additional Findings |
|---|---|---|---|---|---|
| Blood Serum and Plasma Analysis | |||||
| Nishi et al. (2015) [34] | BSA | Glu, Gln | 97 cTEC 8 cPTSD± |
Serum | Elevated serum Glu in cPTSD±; Glu positively correlated with cPTSD severity; Gln/Glu ratio inversely correlated with PTSD severity. |
| Vaiva et al. (2006) [32] | BPA | GABA | 6wks (1yr): 44(22) cPTSD± 34(7) cTEC |
Plasma | Lower plasma GABA in PTSD± at 6 weeks and at 1 year posttrauma; Lower GABA at 6 weeks predicted higher cPTSD± at 1year. |
| Vaiva et al. (2004) [33] | BPA | GABA | 57 cPTSD 51 cTEC 69 HC |
Plasma | Lower plasma GABA in cPTSD compared to cTEC or HC. |
| Schur et al. (2016) [16] | BPA | GABA | 731 TE/CD | Plasma | Increased GABA levels 6-months postdeployment positively correlated with onset of PTSD and other psychopathology |
| DNA / Candidate Gene Studies | |||||
| Zhang et al. (2014) [37] | DNA | SLC1A1 | 264 mPTSD 154 mTEC |
— | RS10739062 was associated with mPTSD diagnosis and severity. |
| 1H-MRS | |||||
| Meyerhoff et al. (2014) [25] | 1H-MRS | GABA, Glu | 27 mPTSD 18 mTEC |
POC TEMP ACC |
Lower GABA in POC and TEMP in mPTSD; reduced POC GABA & elevated POC Glu correlated with increasing insomnia severity; reduced ACC Glu correlated with increased arousal scores. |
| Michels et al. (2014) [28] | 1H-MRS | GABA | 12 cPTSD 17 cTEC |
ACC DLPFC |
Elevated GABA in ACC & DLPFC in cPTSD. |
| Pennington et al. (2014) [26] | 1H-MRS | GABA, Glu, mI | 10 xPAUD 28 xPTSD 20 xTEC |
POC TC ACC |
Lower POC GABA & higher TC Glu in xPTSD compared to xTEC; Lower ACC Glu and mI in xPAUD compared to xPTSD and xTEC; increased GABA and Glu correlated with improved neurocognition in xPAUD. |
| Rosso et al. (2014) [27] | 1H-MRS | GABA | 13 cPTSD 13 HC |
Insula dACC |
Lower insular GABA in cPTSD; reduced insular GABA associated with increased state and trait anxiety in the whole cohort. |
| Yang et al. (2015) [36] | 1H-MRS | Glx | 10 cPTSD-c 23 cPTSD-r 21 HC |
rACC | ACC Glx: cPTSD-c < cPTSD-r < HC. |
| PET | |||||
| Gueze et al. (2008) [30] | PET | GABA(A) BZD receptor |
9 mPTSD 7 mTEC |
Voxel-wise | Lower receptor binding in the cortex, HPC, and THAL in mPTSD. |
| SPECT | |||||
| Bremner et al. (2000) [29] | SPECT | BZD receptor | 13 mPTSD 13 HC |
Voxel-wise | Lower PFC receptor binding in mPTSD |
| Fujita et al. (2004) [31] | SPECT | BZD receptor | 19 mPTSD 19 HC |
Voxel-wise | No difference between groups; Receptor binding negatively correlated with childhood trauma in right STG. |
Abbreviations (methods): BPA = blood plasma analysis; BSA = blood serum analysis; DNA = candidate gene study/DNA isolation and genotyping; 1H-MRS = proton magnetic resonance spectroscopy; PET = positron emission tomography; SPECT = single-photon emission computed tomography. Abbreviations (metabolites/receptors): BZD = benzodiazepine; GABA = gamma-aminobutyric acid; Glu = glutamate; Glx = glutamate + glutamine; mI = Myo-inositol; SLC1A1 = glutamate transporter gene thought to be associated with PTSD; Abbreviations (population): cPTSD = civilian PTSD; cTEC = civilian trauma-exposed control; mPTSD = military PTSD; mTEC = military trauma-exposed control; PTSD = posttraumatic stress disorder; PTSD-c = PTSD current; HC = healthy control; xPAUD = mixed civilian and military PTSD with comorbid alcohol use disorder; PTSD± = full or subthreshold; PTSD-r = PTSD remission; TEC = trauma exposed control; TE/CD = trauma exposed/combat deployment; xPTSD = mixed military and civilian PTSD population; xTEC = mixed military and civilian trauma-exposed control population; Abbreviations (ROIs): ACC = anterior cingulate cortex; dACC = dorsal ACC; DLPFC = dorsolateral prefrontal cortex; HPC = hippocampus; POC = parietooccipital cortex; rACC = rostral ACC; STG = superior temporal gyrus; TEMP = temporal cortex/cortices; THAL = thalamus; Abbreviations (other): CAPS = clinician administered PTSD scale.